Literature DB >> 21673598

Aqueous shunt exposure: a retrospective review of repair outcome.

Stephen M Huddleston1, Robert M Feldman, Donald L Budenz, Nicholas P Bell, David A Lee, Alice Z Chuang, Kimberly A Mankiewicz, Michael S Koval, Elizabeth Truong, Alexei Moraczewski.   

Abstract

PURPOSE: To describe the patient outcomes and factors affecting those outcomes after aqueous shunt exposure repair. PATIENTS AND METHODS: Forty-three eyes from Robert Cizik Eye Clinic and Bascom Palmer Eye Institute from 1995 to 2007 suffered from aqueous shunt exposure and were repaired by participating surgeons. Thirty-three were tube exposures and 7 were plate exposures. The remaining 3 exposure classified complications included a patch graft exposure, an elbow exposure, and 1 unknown complication. Forty eyes were followed for evidence of additional aqueous shunt exposures or additional surgical interventions for 46.6 weeks (40.2 wk) (range: 3 to 168 wk).
RESULTS: Seventeen of 40 eyes required additional surgical intervention: 15 (45%) from the tube exposure group and 2 (29%) from the plate exposure group. Five (13%) eyes needed eventual removal of the shunt. Black race, diabetes mellitus, a high number of glaucoma medications before shunt implantation, a history of multiple glaucoma laser procedures, and combination of an initial aqueous shunt implantation with another surgery were found to be associated with a worse outcome after exposure repair.
CONCLUSIONS: Intraocular pressure, number of medications, and visual acuity remained stable during follow-up after revision. Diabetes mellitus was associated with a shorter average time between initial repair and reintervention, and 4 other variables were associated with a higher likelihood of reintervention.

Entities:  

Mesh:

Year:  2013        PMID: 21673598     DOI: 10.1097/IJG.0b013e3181f3e5b4

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  19 in total

1.  Glaucoma drainage devices: risk of exposure and infection.

Authors:  Joshua D Levinson; Annette L Giangiacomo; Allen D Beck; Paul B Pruett; Hillary M Superak; Michael J Lynn; Anastasios P Costarides
Journal:  Am J Ophthalmol       Date:  2015-05-30       Impact factor: 5.258

Review 2.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

Review 3.  [Revision surgery in episcleral glaucoma drainage devices].

Authors:  A Rosentreter; T S Dietlein
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

4.  Tube shunt coverage with gamma-irradiated cornea allograft (VisionGraft).

Authors:  Feyzahan Ekici; Marlene R Moster; Victor Cvintal; Wanda D Hu; Michael Waisbourd
Journal:  Clin Ophthalmol       Date:  2015-05-04

5.  Risk factors for exposure of glaucoma drainage devices: a retrospective observational study.

Authors:  Kelly W Muir; Annie Lim; Sandra Stinnett; Anthony Kuo; Henry Tseng; Molly M Walsh
Journal:  BMJ Open       Date:  2014-05-02       Impact factor: 2.692

6.  Management of implant plate exposure of silicone Ahmed glaucoma valve: a review of six cases.

Authors:  Avik Kumar Roy; Sirisha Senthil
Journal:  GMS Ophthalmol Cases       Date:  2016-09-02

7.  Risk factors for tube shunt exposure: a matched case-control study.

Authors:  Michael S Koval; Fouad F El Sayyad; Nicholas P Bell; Alice Z Chuang; David A Lee; Stephen M Hypes; Davinder S Grover; Laura A Baker; Stephen M Huddleston; Donald L Budenz; Robert M Feldman
Journal:  J Ophthalmol       Date:  2013-07-21       Impact factor: 1.909

8.  Hypertensive phase and early complications after Ahmed glaucoma valve implantation with intraoperative subtenon triamcinolone acetonide.

Authors:  Angela V Turalba; Louis R Pasquale
Journal:  Clin Ophthalmol       Date:  2014-07-11

9.  Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery.

Authors:  Meenakshi Chaku; Peter A Netland; Kyoko Ishida; Douglas J Rhee
Journal:  Clin Ophthalmol       Date:  2016-03-30

10.  Wound Dehiscence and Device Migration after Subconjunctival Bevacizumab Injection with Ahmed Glaucoma Valve Implantation.

Authors:  Arezoo Miraftabi; Naveed Nilforushan
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.